1. Home
  2. YMAB vs GTE Comparison

YMAB vs GTE Comparison

Compare YMAB & GTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • GTE
  • Stock Information
  • Founded
  • YMAB 2015
  • GTE 2003
  • Country
  • YMAB United States
  • GTE Canada
  • Employees
  • YMAB N/A
  • GTE N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • GTE Oil & Gas Production
  • Sector
  • YMAB Health Care
  • GTE Energy
  • Exchange
  • YMAB Nasdaq
  • GTE Nasdaq
  • Market Cap
  • YMAB 192.4M
  • GTE 178.8M
  • IPO Year
  • YMAB 2018
  • GTE N/A
  • Fundamental
  • Price
  • YMAB $4.60
  • GTE $4.77
  • Analyst Decision
  • YMAB Buy
  • GTE
  • Analyst Count
  • YMAB 11
  • GTE 0
  • Target Price
  • YMAB $17.55
  • GTE N/A
  • AVG Volume (30 Days)
  • YMAB 226.0K
  • GTE 164.7K
  • Earning Date
  • YMAB 05-13-2025
  • GTE 05-01-2025
  • Dividend Yield
  • YMAB N/A
  • GTE N/A
  • EPS Growth
  • YMAB N/A
  • GTE N/A
  • EPS
  • YMAB N/A
  • GTE N/A
  • Revenue
  • YMAB $88,658,000.00
  • GTE $634,805,000.00
  • Revenue This Year
  • YMAB N/A
  • GTE $11.42
  • Revenue Next Year
  • YMAB $16.03
  • GTE N/A
  • P/E Ratio
  • YMAB N/A
  • GTE N/A
  • Revenue Growth
  • YMAB 4.92
  • GTE N/A
  • 52 Week Low
  • YMAB $3.55
  • GTE $3.34
  • 52 Week High
  • YMAB $16.11
  • GTE $10.40
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 56.43
  • GTE 53.34
  • Support Level
  • YMAB $3.99
  • GTE $4.68
  • Resistance Level
  • YMAB $5.00
  • GTE $4.84
  • Average True Range (ATR)
  • YMAB 0.35
  • GTE 0.22
  • MACD
  • YMAB 0.10
  • GTE 0.00
  • Stochastic Oscillator
  • YMAB 70.47
  • GTE 34.31

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.

Share on Social Networks: